ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 955 filers reported holding ISHARES TR in Q4 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,593,736 | -15.1% | 62,098 | -11.8% | 0.10% | -34.9% |
| Q2 2023 | $8,940,935 | -5.7% | 70,425 | -4.0% | 0.15% | -9.9% |
| Q1 2023 | $9,476,758 | -0.6% | 73,373 | +1.1% | 0.16% | -12.4% |
| Q4 2022 | $9,532,498 | +24.5% | 72,608 | +11.0% | 0.18% | +8.2% |
| Q3 2022 | $7,658,000 | -11.8% | 65,394 | -11.3% | 0.17% | -6.6% |
| Q2 2022 | $8,682,000 | -8.8% | 73,747 | +0.9% | 0.18% | +39.7% |
| Q1 2022 | $9,524,000 | +41.0% | 73,096 | +65.2% | 0.13% | -25.6% |
| Q4 2021 | $6,754,000 | -8.8% | 44,254 | -3.4% | 0.18% | -3.8% |
| Q3 2021 | $7,404,000 | +54.2% | 45,796 | +56.1% | 0.18% | +7.6% |
| Q2 2021 | $4,800,000 | +1275.4% | 29,329 | +1170.2% | 0.17% | +709.5% |
| Q1 2021 | $349,000 | +3.3% | 2,309 | +3.6% | 0.02% | -8.7% |
| Q4 2020 | $338,000 | +28.0% | 2,229 | +14.2% | 0.02% | -11.5% |
| Q3 2020 | $264,000 | -63.6% | 1,951 | -63.2% | 0.03% | -64.4% |
| Q2 2020 | $725,000 | – | 5,300 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |